Comparable stake leader
INTRACOASTAL CAPITAL, LLC
SEC ownership of Silo Pharma, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001514183.
Disclosed value leader
INTRACOASTAL CAPITAL, LLC
Comparable rows
17/22
Latest evidence
31 Mar 2026
- Public ticker
- SILO on Nasdaq
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
INTRACOASTAL CAPITAL, LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
17 of 22
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
INTRACOASTAL CAPITAL, LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
31 Mar 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001514183
- Issuer location
- Sarasota, FL
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Silo Pharma, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
INTRACOASTAL CAPITAL, LLC
Disclosed value leader
INTRACOASTAL CAPITAL, LLC
Comparable rows
17/22
Latest evidence
31 Mar 2026
13D/G
13F
3/4/5
Lead comparable stake: 10%
5 rows are not safely comparable across share classes.
13D/G row: INTRACOASTAL CAPITAL, LLC
Showing 1-8 of 22 holder rows.
Quick read
INTRACOASTAL CAPITAL, LLC leads the comparable SEC ownership view at 10%.
17 of 22 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens INTRACOASTAL CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
INTRACOASTAL CAPITAL, LLC
10%
Anson Funds Management LP
4.9%
RENAISSANCE TECHNOLOGIES LLC
0.84%
AdvisorShares Investments LLC
4.7%
GEODE CAPITAL MANAGEMENT, LLC
1.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 22 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| INTRACOASTAL CAPITAL, LLC |
13D/G
Mitchell P. Kopin
|
10%
|
$561,702
1,478,164 shares
|
+$35,627 | 31 Dec 2025 |
| Anson Funds Management LP |
13D/G
|
4.9%
|
$265,805
699,486 shares
|
-$96,100 | 31 Dec 2025 |
| RENAISSANCE TECHNOLOGIES LLC |
13D/G
|
0.84%
|
$30,375
37,500 shares
|
-$153,500 | 31 Dec 2024 |
| AdvisorShares Investments LLC |
13F
Company
|
4.7%
|
$238,828
663,965 shares
|
— | 31 Mar 2026 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
1.3%
|
$64,756
180,031 shares
|
— | 31 Mar 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
0.44%
|
$22,587
62,795 shares
|
— | 31 Mar 2026 |
| JANE STREET GROUP, LLC |
13F
Company
|
0.31%
|
$16,101
44,763 shares
|
— | 31 Mar 2026 |
| CITADEL ADVISORS LLC |
13F
Company
|
0.15%
|
$7,715
21,448 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to buying over the last 12 months. Net value: +$7,657.
Buys
$7,657
Insiders: 1
Sells
$0
Insiders: 0
Net
+$7,657
Shares: +19,000
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 19,000
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 19,000 | 0 | $7,657 | $0 | +$7,657 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-5 of 5 reporting-owner rows connected to Silo Pharma, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
5
Largest Forms 3/4/5 holder
Eric Weisblum
Net 12M change
+$7,657
Latest report
15 Dec 2025
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Eric Weisblum | Chief Executive Officer, Director | $91,111 | +$7,657 | +9.2% | Filing P/S | 15 Dec 2025 |
| Jeff Pavell | Director | Mixed | 23 May 2025 | |||
| Kevin Munoz | Director | Mixed | 23 May 2025 | |||
| Wayne Linsley | Director | Mixed | 23 May 2025 | |||
| Daniel E. Ryweck | Chief Financial Officer | Mixed | 23 May 2025 |
Recent insider transactions for Silo Pharma, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Eric Weisblum | SILO | Common Stock | Purchase | 2.36% | $2,075 | $0.4150 | 5,000 | 216,932 | 15 Dec 2025 | Direct |
| Eric Weisblum | SILO | Common Stock | Purchase | 0.47% | $365 | $0.3650 | 1,000 | 211,932 | 21 Nov 2025 | Direct |
| Eric Weisblum | SILO | Common Stock | Purchase | 0.48% | $370 | $0.3700 | 1,000 | 210,932 | 20 Nov 2025 | Direct |
| Eric Weisblum | SILO | Common Stock | Purchase | 2.19% | $1,822 | $0.4050 | 4,500 | 209,932 | 19 Nov 2025 | Direct |
| Eric Weisblum | SILO | Common Stock | Purchase | 3.79% | $3,025 | $0.4033 | 7,500 | 205,432 | 18 Nov 2025 | Direct |
* marks a reported price that did not pass the local price check.